{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Gly",
          "alt": "Arg",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 Gly2385Arg"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The association between the heterozygote variant of Gly2385Arg and Parkinson's disease suggests a potential disease mechanism involving this variant.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The association between the heterozygote variant of Gly2385Arg and Parkinson's disease suggests a potential disease mechanism involving this variant.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used for this variant effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "name": "Sub-step 3a: Basic Controls and Replicates",
              "internal_question": "Were basic controls included for this assay?",
              "extracted_paper_info": "The paper does not explicitly mention controls or replicates for the functional assay.",
              "judgment": "No",
              "reasoning": "Basic controls and replicates were not mentioned in the Materials and Methods or Results sections.",
              "next_step_or_outcome": "Proceed to Sub-step 3b"
            },
            {
              "name": "Sub-step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
              "internal_question": "Has the specific instance of the assay been broadly accepted historically, previously validated, or provided as a commercial kit with defined performance metrics?",
              "extracted_paper_info": "The paper does not mention specific information about the assay's acceptance, validation, or commercial availability.",
              "judgment": "No",
              "reasoning": "The paper does not provide enough information to determine if the specific assay is broadly accepted, previously validated, or provided as a commercial kit.",
              "next_step_or_outcome": "Do not use PS3/BS3"
            }
          ]
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "N/A"
      },
      "overall_conclusion": "Due to insufficient details about basic controls, replicates, and assay acceptance/validation, we cannot use PS3/BS3 evidence for this variant."
    }
  ]
}